Management of treatment-resistant patients with schizophreniaMARDER, S. R.The Journal of clinical psychiatry. 1996, Vol 57, pp 26-30, issn 0160-6689, SUP11Conference Paper

Facilitating compliance with antipsychotic medicationMARDER, S. R.The Journal of clinical psychiatry. Supplement. 1998, Vol 59, Num 3, pp 21-25Article

Subjective experiences on antipsychotic medications : synthesis and conclusionsMARDER, S. R.Acta psychiatrica scandinavica. Supplementum. 2005, Vol 111, Num 427, pp 43-46, issn 0065-1591, 4 p.Article

Molecular materials for second-order nonlinear optical applicationsMARDER, S. R; PERRY, J. W.Advanced materials (Weinheim). 1993, Vol 5, Num 11, pp 804-815, issn 0935-9648Article

Controlled information processing resources and the development of automatic detection responses in schizophreniaGRANHOLM, E; ASARNOW, R. F; MARDER, S. R et al.Journal of abnormal psychology (1965). 1991, Vol 100, Num 1, pp 22-30, issn 0021-843X, 9 p.Article

Determination of plasma homovanillic acid by column liquid chromatography with electrochemical detectionARAVAGIRI, M; MARDER, S. R; VAN PUTTEN, T et al.Journal of chromatography. Biomedical applications. 1990, Vol 525, Num 2, pp 419-425, issn 0378-4347Article

Synthesis and reactions of bridging (vinylcarbyne)diiron complexesCASEY, C. P; MARDER, S. R.Organometallics. 1985, Vol 4, Num 2, pp 411-413, issn 0276-7333Article

Pharmacokinetics and tissue distribution of olanzapine in ratsARAVAGIRI, M; TEPER, Y; MARDER, S. R et al.Biopharmaceutics & drug disposition. 1999, Vol 20, Num 8, pp 369-377, issn 0142-2782Article

Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of ratARAVAGIRI, M; YUWILER, A; MARDER, S. R et al.Psychopharmacologia. 1998, Vol 139, Num 4, pp 356-363, issn 0033-3158Article

Management of acute extrapyramidal effects induced by antipsychotic drugsHOLLOMAN, L. C; MARDER, S. R.American journal of health-system pharmacy. 1997, Vol 54, Num 21, pp 2461-2477, issn 1079-2082Article

Synthesis of unsymmetrical triarylamines for photonic applications via one-pot palladium-catalyzed aminationsTHAYUMANAVAN, S; BARLOW, S; MARDER, S. R et al.Chemistry of materials. 1997, Vol 9, Num 12, pp 3231-3235, issn 0897-4756Article

Management of schizophreniaMARDER, S. R.The Journal of clinical psychiatry. 1996, Vol 57, pp 9-13, issn 0160-6689, SUP3Conference Paper

Display visual angle and attentional scanpaths on the span of apprehension task in schizophreniaGRANHOLM, E; ASARNOW, R. F; MARDER, S. R et al.Journal of abnormal psychology (1965). 1996, Vol 105, Num 1, pp 17-24, issn 0021-843XArticle

Effect of molecular polarization on bond-length alternation, linear polarizability, first and second hyperpolarizability in donor-acceptor polyenes as a function of chain lengthGORMAN, C. B; MARDER, S. R.Chemistry of materials. 1995, Vol 7, Num 1, pp 215-220, issn 0897-4756Article

AN APPROACH TO TREATMENT RESISTANCE IN SCHIZOPHRENIAMARDER, S. R.British journal of psychiatry. Supplement. 1999, Vol 174, Num 37, pp 19-22, issn 0960-5371, 4 p.Conference Paper

Clinical experience with risperidoneMARDER, S. R.The Journal of clinical psychiatry. 1996, Vol 57, pp 57-61, issn 0160-6689, SUP9Conference Paper

Nonlinear optical polymers : discovery to market in 10 years ?MARDER, S. R; PERRY, J. W.Science (Washington, D.C.). 1994, Vol 263, Num 5154, pp 1706-1707, issn 0036-8075Article

An investigation of the interrelationships between linear and nonlinear polarizabilities and bond-length alternation in conjugated organic moleculesGORMAN, C. B; MARDER, S. R.Proceedings of the National Academy of Sciences of the United States of America. 1993, Vol 90, Num 23, pp 11297-11301, issn 0027-8424Article

A controlled dose comparison of haloperidol in newly admitted schizophrenic patientsVAN PUTTEN, T; MARDER, S. R; MINTZ, J et al.Archives of general psychiatry. 1990, Vol 47, Num 8, pp 754-758, issn 0003-990X, 5 p.Article

Pharmacological treatment strategies in acute schizophreniaMARDER, S. R.International clinical psychopharmacology. 1996, Vol 11, pp 29-34, issn 0268-1315, SUP2Conference Paper

The role of dosage and plasma levels in neuroleptic relapse preventionMARDER, S. R.Acta psychiatrica scandinavica. Supplementum. 1994, Vol 89, Num 382, pp 25-27, issn 0065-1591Conference Paper

Psychopharmacologic treatment of schizophreniaKANE, J. M; MARDER, S. R.Schizophrenia bulletin. 1993, Vol 19, Num 2, pp 287-302, issn 0586-7614Article

Serum prolactin as a correlate of clinical response to haloperidolVAN PUTTEN, T; MARDER, S. R; MINTZ, J et al.Journal of clinical psychopharmacology. 1991, Vol 11, Num 6, pp 357-361, issn 0271-0749Article

Recent development of highly efficient chromophores and polymers for electro-optic device applicationsJEN, A. K.-Y; HONG MA; XIAOMING WU et al.SPIE proceedings series. 1999, pp 112-119, isbn 0-8194-3093-5Conference Paper

Risperidone in treatment-refractory schizophreniaWIRSHING, D. A; MARSHALL, B. D; GREEN, M. F et al.The American journal of psychiatry. 1999, Vol 156, Num 9, pp 1374-1379, issn 0002-953XArticle